Tsh high >100 borderline low t4, patient on levothyroxine 75. Patient had low tsh so go had reduced the dose to 50mcg few months ago and patient has missed taking levothyroxine , why does the patient have high tsh now >100

Reading File
Reading File
Finding Sources
Finding Sources
Searching PubMed

"hypothyroidism"[MeSH Terms] AND "levothyroxine" AND "nonadherence"

The most likely explanation is a combination of the dose cut, erratic intake, and the way TSH responds to small changes in thyroid hormone. Other causes need excluding before you escalate the dose.

Why TSH is so high

1. TSH amplifies small changes in free T4. The TSH-fT4 relationship is log-linear. A modest fall in fT4 produces a large rise in TSH. Cutting 75 to 50 mcg is a 33% reduction. Add missed doses and the effective intake may be a fraction of what the patient needs. Levothyroxine's half-life is about 7 days, and steady state takes about 6 weeks (Symptom to Diagnosis, 4th ed, Treatment section). TSH therefore keeps climbing for weeks after intake falls. A TSH above 100 usually means a sustained period of under-replacement, not a few missed tablets.
2. Poor adherence is common and often hidden.
  • Up to 50% of patients on long-term levothyroxine have TSH above range because of poor compliance (Tietz Textbook of Laboratory Medicine, 7th ed, Treatment of Hypothyroidism).
  • Tietz also lists poor compliance as a cause of raised TSH with normal or borderline fT4.
  • A borderline low T4 with a very high TSH is typical of this pattern. Some patients take the tablet in the days before the blood test, which lifts fT4 partly. TSH responds more slowly, so it stays very high.
3. The earlier low TSH may have been misleading. The earlier suppressed TSH was probably not true over-replacement. Possible reasons:
  • Erratic dosing, such as extra tablets just before the test.
  • Residual thyroid function or recovering thyroiditis.
  • Recovery from non-thyroidal illness.
  • A drug or biotin effect on the assay.
If the dose was cut on the strength of one low TSH, it may have been too aggressive. The patient's real requirement is probably closer to 75 mcg or more.
4. Malabsorption or interacting drugs. Check for these, as they raise the required dose:
  • Calcium, iron, antacids, sucralfate, and bile acid sequestrants (Goodman & Gilman's, levothyroxine dosage requirements table).
  • PPIs and taking the tablet with food or coffee (Katzung's, Case Study Answer).
  • Other causes: celiac disease, atrophic gastritis, H. pylori, and bariatric surgery or short gut.
  • Increased metabolism from rifampin, sertraline, or anticonvulsants (Berek & Novak's, Treatment).
  • Other causes of higher requirement: weight gain, pregnancy, tyrosine kinase inhibitors, and loss of residual thyroid function in Hashimoto's.
5. Assay interference. Consider this if the clinical picture does not fit.
  • Biotin supplements can falsely alter immunoassays.
  • Heterophile antibodies and macro-TSH can cause a falsely high TSH.
  • Tietz lists heterophilic antibody interference among the causes of raised TSH with normal fT4.
  • Repeat the test on a different platform, with PEG precipitation for macro-TSH if needed.
  • Stop biotin for at least 48 to 72 hours before retesting.

Suggested approach

  1. Ask directly about adherence, the timing of doses relative to food, and any new supplements or drugs.
  2. Look for symptoms and signs of significant hypothyroidism. Check lipids, CK, and sodium. Urgent assessment is needed only if there are features of myxedema, such as hypothermia, bradycardia, or altered mentation.
  3. Restore a consistent daily dose. About 1.6 mcg/kg/day is a typical full replacement dose, with an age and cardiac adjustment. Avoid a big jump if the patient has been taking tablets intermittently, because they may overshoot once they take it reliably.
  4. Recheck TSH and fT4 after 6 to 8 weeks of consistent dosing. If adherence is the problem, a once-weekly dose is an option.
  5. Screen for celiac disease and gastric causes if TSH stays high despite confirmed adherence and a proper dose.
Recent evidence. A 2025 meta-analysis of RCTs looked at the timing and scheduling of levothyroxine and adherence (da Rocha et al., PMID 40220082). It does not change the reasoning above. I did not read the full text, so I can't say what it concludes on dosing schedules.
If you share the fT4 value, weight, the patient's symptoms, and any other medications, I can narrow this down further.

If I call the endocrine Spr inpatient , what will be the plan, give me a plan 1234

Here is the plan an endocrine SpR would most likely give. The details change with how unwell the patient is.
1. Is this myxedema or just biochemistry?
  • Check observations: temperature, HR, BP, RR, SpO2, glucose, GCS.
  • Look for hypothermia, bradycardia, hypotension, hypoventilation, hyponatraemia, confusion, effusions, or ileus.
  • If the patient is well, with only a borderline low fT4 and no features of decompensation, this is severe uncomplicated hypothyroidism. It does not need IV treatment and can be managed with oral levothyroxine.
  • If there are features of myxedema coma, they will advise HDU/ICU, IV levothyroxine, and IV hydrocortisone. A typical regimen is hydrocortisone 100 mg IV every 8 hours until adrenal insufficiency is excluded, and local protocols vary. They will also look for a precipitant such as sepsis, drugs, or cold exposure.
2. Investigations to have ready
  • Repeat TSH, fT4, and fT3.
  • Morning cortisol, or a random cortisol if the patient is unwell. Autoimmune adrenal insufficiency can coexist, and thyroid hormone can precipitate an adrenal crisis.
  • U&E (especially sodium), glucose, FBC, CK, lipids, and LFTs.
  • ECG, plus a CXR or echo if there are signs of effusion or heart failure.
  • TPO antibodies if not already known. Also tissue transglutaminase IgA (coeliac) and B12.
  • A drug history for calcium, iron, PPIs, antacids, biotin, amiodarone, lithium, and TKIs.
  • If adherence is genuinely good and TSH is still above 100, ask the lab about biotin, heterophile antibody, or macro-TSH interference.
3. Treatment
  • Restart oral levothyroxine as an inpatient, given on an empty stomach 30 to 60 minutes before food and away from calcium or iron. Supervised doses also give a real picture of adherence.
  • Dose: the previous 75 mcg is a reasonable restart for a patient with known requirements. They may go up to a full replacement dose of about 1.6 mcg/kg if the patient is young with no cardiac disease.
  • If the patient is elderly or has ischaemic heart disease or AF, they will start lower (25 to 50 mcg) and titrate.
  • Do not chase the TSH with early dose escalation. TSH lags fT4 by about 6 weeks.
  • If there is a cortisol concern, they will cover with steroids before or alongside levothyroxine.
4. Disposition and follow-up
  • If stable, discharge is usually fine with an outpatient plan. They do not need a long admission.
  • Address why doses were missed: education, a pill organiser or alarm, and one fixed daily routine. If adherence stays poor, they may suggest a once-weekly dose (about 7 times the daily dose, with the endocrine team agreeing the dose).
  • Repeat TSH and fT4 at 6 to 8 weeks, then titrate in 12.5 to 25 mcg steps. Dose changes should not rest on a single low TSH.
  • Communicate the plan to the GP, including the fact that the earlier dose reduction was probably based on unreliable intake.
What they will ask you
  • How the patient looks (observations, mental state)
  • The actual fT4 value
  • Whether the patient is on other medications
  • Whether they are pregnant, elderly, or have cardiac disease
  • Any known adrenal or other autoimmune disease
Have these ready before you call.

Has Thrombocytopenia ?cause

Finding Sources
Finding Sources
Searching PubMed

"hypothyroidism"[MeSH Terms] AND "thrombocytopenia"[MeSH Terms]

Thrombocytopenia is not a recognised feature of hypothyroidism, so I would look for a second cause rather than blame the TSH of more than 100.

What hypothyroidism does to the blood

  • It typically causes a mild normocytic or slightly macrocytic anaemia. This is due to low erythropoietin and possibly a hypocellular marrow (Tietz Textbook of Laboratory Medicine, 7th ed, Signs; Rosen's Emergency Medicine, Clinical Features).
  • It can cause acquired von Willebrand syndrome and platelet function problems. These produce bleeding with a normal or near-normal count (Tietz, reference on acquired von Willebrand syndrome associated with hypothyroidism).
  • I found nothing in the library describing true thrombocytopenia as a direct effect. A PubMed search for recent systematic reviews on hypothyroidism and thrombocytopenia returned nothing relevant. Rare case reports exist, but I can't cite them.

Likely causes in this patient

1. Pseudothrombocytopenia (EDTA clumping). Look at the blood film first. If platelets are clumped, repeat the count in a citrate tube.
2. Autoimmune.
  • Immune thrombocytopenia (ITP) clusters with autoimmune thyroid disease, because polyautoimmunity is common. Harrison's lists autoimmune thrombocytopenia alongside autoimmune hypothyroidism.
  • Also consider SLE, antiphospholipid syndrome, and Evans syndrome (ITP with autoimmune haemolysis).
3. B12 or folate deficiency.
  • Pernicious anaemia often coexists with Hashimoto's. It causes macrocytosis, and in severe cases pancytopenia.
  • Atrophic gastritis and coeliac disease would also fit the poor levothyroxine control.
  • Look for a raised MCV, hypersegmented neutrophils, a low reticulocyte count, and a raised LDH and bilirubin.
4. Liver disease or alcohol.
  • Alcohol or chronic liver disease can lower platelets through marrow suppression or hypersplenism.
  • Alcohol or mental health problems may also explain the missed doses.
5. Drugs.
  • Heparin (consider HIT if the patient is an inpatient on heparin, and check the timing)
  • Antibiotics (for example linezolid or trimethoprim-sulfamethoxazole)
  • Valproate, carbamazepine, and PPIs
  • Lithium or amiodarone, which are thyroid-relevant
  • Check every new drug started in the last 1 to 2 weeks.
6. Infection. HIV, hepatitis C (it also causes thyroid disease and ITP), and H. pylori (ITP and atrophic gastritis). Sepsis with DIC is also possible.
7. Marrow disease. MDS, leukaemia, or myeloma. These are more likely if other lines are low, or if there are blasts or dysplasia on the film.
8. Thrombotic microangiopathy (TTP, HUS).
  • Look for schistocytes on the film, haemolysis, renal impairment, fever, or neurological change.
  • Hypothyroid confusion can mimic this, so do not dismiss it.
9. Pregnancy. Consider gestational thrombocytopenia if the patient could be pregnant.

Work-up

  • FBC with film, reticulocytes, and MCV. Check whether other lines are low.
  • B12, folate, ferritin, LFTs, LDH, bilirubin, haptoglobin, DAT, and urea and creatinine.
  • PT, APTT, and fibrinogen.
  • HIV, hepatitis B, and hepatitis C serology.
  • ANA, dsDNA, and antiphospholipid antibodies.
  • Tissue transglutaminase IgA, intrinsic factor and parietal cell antibodies, and H. pylori testing.
  • Abdominal ultrasound for spleen size and liver.
  • If there is mucocutaneous bleeding with a near-normal count, ask about von Willebrand factor levels. Acquired vWS from hypothyroidism improves with thyroid replacement.

Urgency

  • Treat as urgent and involve haematology if platelets are below 20, there is active bleeding, or other cell lines are also low.
  • Check platelets before any procedure, and avoid IM injections if the count is low.
  • Tell the endocrine SpR when you call. A coexisting autoimmune process raises the chance of adrenal involvement, so cortisol matters even more before starting levothyroxine.
If you have the platelet count, Hb, MCV, and WCC, I can narrow the list further.
This is a shared conversation. Sign in to Orris to start your own chat.